Skip to main content
. 2020 Jan 26;8(2):255–263. doi: 10.12998/wjcc.v8.i2.255

Table 2.

Laboratory examinations

MACE group (n = 20) Event-free group (n = 30) P value
WBC (×109/L) 15.16 ± 7.12 9.11 ± 3.20 0.002
NEUT (×109/L) 12.88 ± 6.88 6.66 ± 2.94 0.001
Hemoglobin (g/L) 123.36 ± 21.04 136.11 ± 18.03 0.026
Platelets (×109/L) 171.89 ± 115.79 208.85 ± 69.53 0.165
ALT (U/L) 133.50 (65.25-1584.25) 72.00 (38.75-446.25) 0.076
BUN 9.60 (6.36-17.00) 5.55 (4.11-7.67) < 0.001
Creatine (μmol/L) 109.65 (78.35-322.65) 79.45 (66.70-87.48) 0.003
Troponin I (ng/mL) 28.80 (8.35-87.95) 10.30 (2.22-28.61) 0.012
Peak troponin I (ng/mL) 34.92 (15.74-100.26) 12.09 (2.38-48.44) 0.014
CK-MB (ng/mL) 94.30 (31.00-122.10) 21.40 (6.70-64.60) 0.004
Peak CK-MB (ng/mL) 116.10 (66.10-170.60) 22.30 (7.40-68.30) 0.002
CK (U/L) 959.00 (307.00-1432.00) 423.00 (149.50-710.00) 0.044
Peak CK (U/L) 1545.00 (821.00-2067.00) 464.00 (206.25-860.00) 0.010
D-dimer (μg/L) 1706.00 (493.00-8608.00) 303.00 (86.00-620.75) 0.001
Lactic acid (mmol/L) 3.35 (2.03-6.83) 1.45 (0.98-1.93) < 0.001

MACE: Major adverse cardiovascular events; WBC: White blood cells; NEUT: Neutrophils; ALT: Alanine aminotransferase; BUN: Blood urea nitrogen; CK: Creatine kinase.